US Hereditary Angioedema Association - Press Release - Ionis reports positive topline Phase 2 study results of its novel antisense treatment for hereditary angioedema

Press Release
March 29th, 2021
Ionis reports positive topline Phase 2 study results of its novel antisense treatment for hereditary angioedema